Clinical Trials Browser

Phase 1/2 × Advanced Cancer × Other solid neoplasm × Clear all

NCT06656390 2026-03-06

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Cancer